Review



b16f10 pdl1 cell  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC b16f10 pdl1 cell
    AUC for LLC1 lung cancer growth in males, and MC38 colorectal cancer growth in females ( A & B ), B16F10 skin cancer growth in males and females, respectively ( C & D ). Representative images of tumor growth of B16F10 melanoma in males ( E ). An approximation scale for in vivo degree of response ( F ). Data shows a representative experiment for each cancer model. B16F10 was conducted four times in males, two times in <t>females;</t> <t>B16F10-PDL1</t> one time in males and one time in females, LLC1 one time in males, and MC38 two times in females . For AUC statistical analyses, parametric unpaired two-tailed t-tests were used. *p < 0.05, **p < 0.01 and ***p < 0.001 .
    B16f10 Pdl1 Cell, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 8355 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b16f10 pdl1 cell/product/ATCC
    Average 99 stars, based on 8355 article reviews
    b16f10 pdl1 cell - by Bioz Stars, 2026-02
    99/100 stars

    Images

    1) Product Images from "Rasal1 impairment unleashes anticancer immunity - a focus on T cells"

    Article Title: Rasal1 impairment unleashes anticancer immunity - a focus on T cells

    Journal: bioRxiv

    doi: 10.64898/2026.01.19.700452

    AUC for LLC1 lung cancer growth in males, and MC38 colorectal cancer growth in females ( A & B ), B16F10 skin cancer growth in males and females, respectively ( C & D ). Representative images of tumor growth of B16F10 melanoma in males ( E ). An approximation scale for in vivo degree of response ( F ). Data shows a representative experiment for each cancer model. B16F10 was conducted four times in males, two times in females; B16F10-PDL1 one time in males and one time in females, LLC1 one time in males, and MC38 two times in females . For AUC statistical analyses, parametric unpaired two-tailed t-tests were used. *p < 0.05, **p < 0.01 and ***p < 0.001 .
    Figure Legend Snippet: AUC for LLC1 lung cancer growth in males, and MC38 colorectal cancer growth in females ( A & B ), B16F10 skin cancer growth in males and females, respectively ( C & D ). Representative images of tumor growth of B16F10 melanoma in males ( E ). An approximation scale for in vivo degree of response ( F ). Data shows a representative experiment for each cancer model. B16F10 was conducted four times in males, two times in females; B16F10-PDL1 one time in males and one time in females, LLC1 one time in males, and MC38 two times in females . For AUC statistical analyses, parametric unpaired two-tailed t-tests were used. *p < 0.05, **p < 0.01 and ***p < 0.001 .

    Techniques Used: In Vivo, Two Tailed Test

    Survival in females and AUC in males derived from intradermal implantation of B16F10-PDL1 cells ( A-B ). Counts of infiltrating T cells and CD8 + T cells within B16F10-PDL1 melanoma ( C-D ). Percent CD44 + and CD69 + cells within gated effector CD8 + TILs in B16F10-PDL1 melanoma ( E-F ). For statistical analyses, parametric one-way ANOVAs were used, with multiple comparisons. *p < 0.05, **p < 0.01 and ***p < 0.001 .
    Figure Legend Snippet: Survival in females and AUC in males derived from intradermal implantation of B16F10-PDL1 cells ( A-B ). Counts of infiltrating T cells and CD8 + T cells within B16F10-PDL1 melanoma ( C-D ). Percent CD44 + and CD69 + cells within gated effector CD8 + TILs in B16F10-PDL1 melanoma ( E-F ). For statistical analyses, parametric one-way ANOVAs were used, with multiple comparisons. *p < 0.05, **p < 0.01 and ***p < 0.001 .

    Techniques Used: Derivative Assay



    Similar Products

    b16f10 pdl1 cell  (ATCC)
    99
    ATCC b16f10 pdl1 cell
    AUC for LLC1 lung cancer growth in males, and MC38 colorectal cancer growth in females ( A & B ), B16F10 skin cancer growth in males and females, respectively ( C & D ). Representative images of tumor growth of B16F10 melanoma in males ( E ). An approximation scale for in vivo degree of response ( F ). Data shows a representative experiment for each cancer model. B16F10 was conducted four times in males, two times in <t>females;</t> <t>B16F10-PDL1</t> one time in males and one time in females, LLC1 one time in males, and MC38 two times in females . For AUC statistical analyses, parametric unpaired two-tailed t-tests were used. *p < 0.05, **p < 0.01 and ***p < 0.001 .
    B16f10 Pdl1 Cell, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/b16f10 pdl1 cell/product/ATCC
    Average 99 stars, based on 1 article reviews
    b16f10 pdl1 cell - by Bioz Stars, 2026-02
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    AUC for LLC1 lung cancer growth in males, and MC38 colorectal cancer growth in females ( A & B ), B16F10 skin cancer growth in males and females, respectively ( C & D ). Representative images of tumor growth of B16F10 melanoma in males ( E ). An approximation scale for in vivo degree of response ( F ). Data shows a representative experiment for each cancer model. B16F10 was conducted four times in males, two times in females; B16F10-PDL1 one time in males and one time in females, LLC1 one time in males, and MC38 two times in females . For AUC statistical analyses, parametric unpaired two-tailed t-tests were used. *p < 0.05, **p < 0.01 and ***p < 0.001 .

    Journal: bioRxiv

    Article Title: Rasal1 impairment unleashes anticancer immunity - a focus on T cells

    doi: 10.64898/2026.01.19.700452

    Figure Lengend Snippet: AUC for LLC1 lung cancer growth in males, and MC38 colorectal cancer growth in females ( A & B ), B16F10 skin cancer growth in males and females, respectively ( C & D ). Representative images of tumor growth of B16F10 melanoma in males ( E ). An approximation scale for in vivo degree of response ( F ). Data shows a representative experiment for each cancer model. B16F10 was conducted four times in males, two times in females; B16F10-PDL1 one time in males and one time in females, LLC1 one time in males, and MC38 two times in females . For AUC statistical analyses, parametric unpaired two-tailed t-tests were used. *p < 0.05, **p < 0.01 and ***p < 0.001 .

    Article Snippet: The cell lines derive from ATCC, except for the B16F10-PDL1 cell which was kindly donated to us by Dr Michel Ardolino of the University of Ottawa, ON, Canada[ ].

    Techniques: In Vivo, Two Tailed Test

    Survival in females and AUC in males derived from intradermal implantation of B16F10-PDL1 cells ( A-B ). Counts of infiltrating T cells and CD8 + T cells within B16F10-PDL1 melanoma ( C-D ). Percent CD44 + and CD69 + cells within gated effector CD8 + TILs in B16F10-PDL1 melanoma ( E-F ). For statistical analyses, parametric one-way ANOVAs were used, with multiple comparisons. *p < 0.05, **p < 0.01 and ***p < 0.001 .

    Journal: bioRxiv

    Article Title: Rasal1 impairment unleashes anticancer immunity - a focus on T cells

    doi: 10.64898/2026.01.19.700452

    Figure Lengend Snippet: Survival in females and AUC in males derived from intradermal implantation of B16F10-PDL1 cells ( A-B ). Counts of infiltrating T cells and CD8 + T cells within B16F10-PDL1 melanoma ( C-D ). Percent CD44 + and CD69 + cells within gated effector CD8 + TILs in B16F10-PDL1 melanoma ( E-F ). For statistical analyses, parametric one-way ANOVAs were used, with multiple comparisons. *p < 0.05, **p < 0.01 and ***p < 0.001 .

    Article Snippet: The cell lines derive from ATCC, except for the B16F10-PDL1 cell which was kindly donated to us by Dr Michel Ardolino of the University of Ottawa, ON, Canada[ ].

    Techniques: Derivative Assay